Moreover, experiments using CRISPR/CAS9 technology recently showed that phosphorylation at RyR2 CaMKII-specific site Serine-2814 is necessary to reveal CPVT phenotype [63]. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.